Alkyl Amines Chemicals Ltd Q2 FY26 Earnings Analysis
Published 19 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹9.9K Cr
Price
₹1,895
Market Cap
₹9.9K Cr
P/E Ratio
44.1
How does Alkyl Amines Chemicals Ltd rank in Chemicals & Petrochemicals?
Compare Alkyl Amines Chemicals Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Earnings Summary
Volume growth in H1 FY'26 was marginally up but below the usual 10-15% annual growth expectation due to subdued demand. The first half of FY'26 has been subdued with marginal volume growth and flat topline due to demand pressures and geopolitical factors. - Volume growth expected to be lower than the usual 10-15% for FY'26. - Margins have been protected despite pricing pressures. - Demand is currently subdued across agrochemicals, pharma, and other industries but may improve if global trade volatility settles. - Capacity expansions, such as the new plant with a CAPEX of ~Rs.
📊 Revenue & Sales Performance
- →Volume growth in H1 FY'26 was marginally up but below the usual 10-15% annual growth expectation due to subdued demand.
- →Full year FY'26 volume growth is expected to remain subdued owing to global geopolitical and trade challenges.
- →Demand in methylamines impacted more than ethylamines, with ethylamines focused more on the domestic market.
- →Capacity utilization and demand growth for products like acetonitrile depend on market conditions; capacity expansion decisions will be made once utilization nears limits.
- →New product launches are expected by early 2026-27, with positive outlook on profitability and potential import substitution.
- →Overall, growth is anticipated to return once global trade volatility settles and normal business cycles resume.
- →Long-term, the company aims for gradual upward volume trends, with capacity to scale production up to ~2 lakh tons (production) depending on market demand.
📈 Profitability & Margins
- →The first half of FY'26 has been subdued with marginal volume growth and flat topline due to demand pressures and geopolitical factors.
- →Volume growth expected to be lower than the usual 10-15% for FY'26.
- →Margins have been protected despite pricing pressures.
- →Demand is currently subdued across agrochemicals, pharma, and other industries but may improve if global trade volatility settles.
- →Capacity expansions, such as the new plant with a CAPEX of ~Rs. 120 crores, are expected to come online by early FY'27, potentially driving volume growth.
- →Acetonitrile capacity utilization may require expansion if demand grows; exports continue worldwide.
- →Overall growth depends on normalization of global trade and market demand; positive trend expected post volatility.
- →Management optimistic about returning to normal growth levels similar to or above pre-COVID volumes and profitability over time.
🏗️ Capital Expenditure Plans
- →Alkyl Amines Chemicals has ongoing capital expenditure at Kurkumbh for a new product, expected to be mechanically completed between February-March 2026, with commercialization in Q1 of FY 2026-27.
- →The CAPEX for this new product is approximately Rs. 120 crores.
- →This product targets dyes, pigments, electronics sectors and serves as an import substitute, with no current domestic competitor.
- →Asset turnover expected for this new product is about 1.5 times.
- →For acetonitrile (ACN), potential future capacity expansion depends on market growth and capacity utilization; no immediate CAPEX decisions will be made until utilization justifies it.
- →Typical timeline for setting up a continuous process plant is about 2 years, including around 1 year for environment clearances.
- →Last plant setup was in the range of Rs. 150-160 crores, possibly higher now.
💰 Fundraising & Capital Structure
- →There is no specific mention of any current or future fundraising through debt or equity in the provided transcript.
- →The company discussed capital expenditure (CAPEX) plans, e.g., a new plant costing around ₹120 crore with commissioning expected in early FY 2026-27, but did not specify the mode of funding.
- →Investment decisions, especially for expansions like acetonitrile capacity, will be made based on market demand and capacity utilization, indicating caution towards large investments.
- →No direct reference was made to raising funds via debt or equity during the call.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Alkyl Amines Chemicals Ltd Q2 FY26 results?
Volume growth in H1 FY'26 was marginally up but below the usual 10-15% annual growth expectation due to subdued demand. The first half of FY'26 has been subdued with marginal volume growth and flat topline due to demand pressures and geopolitical factors. - Volume growth expected to be lower than the usual 10-15% for FY'26. - Margins have been protected despite pricing pressures. - Demand is currently subdued across agrochemicals, pharma, and other industries but may improve if global trade volatility settles. - Capacity expansions, such as the new plant with a CAPEX of ~Rs.
What is Alkyl Amines Chemicals Ltd share price analysis?
Alkyl Amines Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 44.1 with a market cap of ₹9,921 Cr. Investors should review the full earnings analysis for detailed insights.
Is Alkyl Amines Chemicals Ltd planning capital expenditure?
Alkyl Amines Chemicals has ongoing capital expenditure at Kurkumbh for a new product, expected to be mechanically completed between February-March 2026, with commercialization in Q1 of FY 2026-27. - The CAPEX for this new product is approximately Rs.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.